Use of gonadotropin-releasing hormone agonists before myomectomy.
Friedman
A J
AJ
Harvard Medical School, Boston, Massachusetts.
D002985:Clinical Protocols; D003131:Combined Modality Therapy; D016903:Drug Monitoring; D004958:Estradiol / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use*; D006062:Gonadotropins / Q000097:blood; D006801:Humans; D007889:Leiomyoma / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000601:surgery*; D007986:Luteinizing Hormone / Q000097:blood; D011300:Preoperative Care; D014463:Ultrasonography; D014594:Uterine Neoplasms / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000601:surgery*
D006062:Gonadotropins; D007987:Gonadotropin-Releasing Hormone; D004958:Estradiol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone